康芝药业
(300086)
| 流通市值：27.45亿 | | | 总市值：28.35亿 |
| 流通股本：4.41亿 | | | 总股本：4.55亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 17,269,378.96 | 59,751,946.26 | 17,952,248.56 | 47,457,968.17 |
| 应收票据及应收账款 | 41,878,482.59 | 44,161,220.74 | 49,710,272.05 | 60,948,662.32 |
| 其中：应收票据 | 1,349,000 | 7,394,827.26 | 3,105,773 | 6,270,000 |
| 应收账款 | 40,529,482.59 | 36,766,393.48 | 46,604,499.05 | 54,678,662.32 |
| 预付款项 | 36,551,072.16 | 26,846,887.06 | 42,990,620.12 | 28,798,257.08 |
| 其他应收款合计 | 10,718,629.95 | 11,633,013.23 | 28,265,040.42 | 27,868,385.77 |
| 存货 | 160,328,103.04 | 160,116,913.86 | 166,890,605.3 | 167,845,478 |
| 其他流动资产 | 2,061,122.26 | 1,968,637.98 | 4,455,811.63 | 3,381,547.37 |
| 流动资产合计 | 268,806,788.96 | 304,478,619.13 | 310,264,598.08 | 336,300,298.71 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 4,973,239.88 | 4,973,239.88 | 4,973,239.88 | 4,973,239.88 |
| 投资性房地产 | 556,070,287.16 | 556,070,287.16 | 564,864,039.8 | 243,084,839.8 |
| 固定资产 | 672,052,042.96 | 680,021,426.41 | 686,665,916.96 | 969,802,540.87 |
| 在建工程 | 16,048,608.95 | 18,004,948.24 | 18,500,224.44 | 15,462,518.85 |
| 使用权资产 | 16,905,641.17 | 17,147,150.32 | 17,388,659.5 | 17,630,168.65 |
| 无形资产 | 61,602,601.14 | 63,710,972.73 | 101,847,538.5 | 145,830,772.76 |
| 开发支出 | 31,074,368.55 | 31,074,368.55 | 55,600,814.49 | 53,541,380.52 |
| 商誉 | 8,300,000 | 8,300,000 | 13,500,000 | 13,500,000 |
| 长期待摊费用 | 25,060,784.01 | 24,794,106.07 | 26,318,261.85 | 28,540,741.01 |
| 递延所得税资产 | 64,933,209.65 | 70,744,648.69 | 65,154,818.78 | 56,970,570.83 |
| 其他非流动资产 | 11,403,211.83 | 11,684,999.3 | 14,344,385.59 | 19,821,659.12 |
| 非流动资产合计 | 1,468,423,995.3 | 1,486,526,147.35 | 1,569,157,899.79 | 1,569,158,432.29 |
| 资产总计 | 1,737,230,784.26 | 1,791,004,766.48 | 1,879,422,497.87 | 1,905,458,731 |
| 流动负债: | | | | |
| 短期借款 | 153,550,332.4 | 166,045,244.17 | 166,569,336.55 | 124,799,882.1 |
| 应付票据及应付账款 | 60,782,353.76 | 52,713,437.25 | 52,819,801.01 | 49,502,465.12 |
| 应付账款 | 60,782,353.76 | 52,713,437.25 | 52,819,801.01 | 49,502,465.12 |
| 预收款项 | 1,195,850.2 | 262,797.81 | 394,346 | 731,063.65 |
| 合同负债 | 14,519,146.19 | 24,533,858.99 | 16,730,600.59 | 36,347,243.25 |
| 应付职工薪酬 | 7,407,049.54 | 8,589,375.15 | 7,604,136.68 | 7,730,244.97 |
| 应交税费 | 12,930,248.1 | 15,623,473.53 | 13,683,454.51 | 10,684,244.15 |
| 其他应付款合计 | 208,977,523.03 | 230,790,291.79 | 159,381,038.95 | 154,780,357.47 |
| 一年内到期的非流动负债 | 81,241,330.99 | 81,171,331.32 | 67,446,610.84 | 88,446,610.84 |
| 其他流动负债 | 1,884,045.3 | 3,762,054.38 | 2,174,978.07 | 4,721,457.43 |
| 流动负债合计 | 542,487,879.51 | 583,491,864.39 | 486,804,303.2 | 477,743,568.98 |
| 非流动负债: | | | | |
| 长期借款 | 181,820,000 | 181,820,000 | 233,065,000 | 233,065,000 |
| 租赁负债 | 17,846,995.66 | 17,657,309.09 | 19,194,513.15 | 19,012,665.87 |
| 递延收益 | 53,150,276.84 | 53,891,384.81 | 54,642,909.44 | 55,394,434.07 |
| 递延所得税负债 | 32,868,016.51 | 32,928,393.8 | 36,532,587.43 | 34,456,113.55 |
| 非流动负债合计 | 285,685,289.01 | 286,297,087.7 | 343,435,010.02 | 341,928,213.49 |
| 负债合计 | 828,173,168.52 | 869,788,952.09 | 830,239,313.22 | 819,671,782.47 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 455,124,411 | 455,124,411 | 455,124,411 | 455,124,411 |
| 资本公积 | 842,991,008.41 | 842,991,008.41 | 842,991,008.41 | 842,991,008.41 |
| 其他综合收益 | 66,049,440.12 | 66,068,602.22 | 58,130,740.62 | 51,719,218.63 |
| 盈余公积 | 54,941,795.33 | 54,941,795.33 | 54,941,795.33 | 54,941,795.33 |
| 未分配利润 | -531,166,074.8 | -519,416,329.73 | -385,889,167.65 | -343,359,390.57 |
| 归属于母公司股东权益合计 | 887,940,580.06 | 899,709,487.23 | 1,025,298,787.71 | 1,061,417,042.8 |
| 少数股东权益 | 21,117,035.68 | 21,506,327.16 | 23,884,396.94 | 24,369,905.73 |
| 股东权益合计 | 909,057,615.74 | 921,215,814.39 | 1,049,183,184.65 | 1,085,786,948.53 |
| 负债和股东权益合计 | 1,737,230,784.26 | 1,791,004,766.48 | 1,879,422,497.87 | 1,905,458,731 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-27 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |